Clinical trials status

Click on the title to get more information.

Recruiting Phase I single site study using Heat Activated Liposomal Doxorubicin and Hyperthermia to treat patients with loco-regional recurrent breast cancer
Conditions: Loco-regional breast carcinoma of the chest wall and /or its overlying skin, with or without metastases
Recruiting Phase III Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Interventions: Drug: ThermoDox; Drug: 5% Dextrose Solution
Recruiting A Study of ThermoDox in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver
Conditions: Hepatocellular Carcinoma; Liver Neoplasms
Intervention: Drug: ThermoDox
No Longer Recruiting Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
Conditions: Liver Cancer; Metastatic Cancer
Interventions: Drug: lyso-thermosensitive liposome doxorubicin; Procedure: chemotherapy; Procedure: radiofrequency ablation

For further information on all clinical trials please refer to www.clinicaltrials.gov.



Copyright © 2008 Celsion Corporation. Home  |  Privacy Policy  |  Governance  |  Media  |  Site Map